1,6-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95%, 1g

(S)-2-Amino-3-(4-fluoro-3-hydroxyphenyl)propanoic acid hydrochloride, 98%, 250mg

Hexano (isómeros), mínimo 95 % (isómeros), para síntesis, 25 l, blanco.

1-((3,5-DICHLOROPHENYL)SULFONYL)-N-(4-FLUOROBENZYL)PIPERIDINE-4-CARBOXAMIDE, 95%, 50mg

2-Chloro-3-iodopyridine, 99.0%, 100g

(6-CHLORO-2-METHYLPYRIDIN-3-YL)METHANOL, 95.0%, 500mg

1-Chloroadamantane, 95.0%, 5g

(R)-1-(3-Nitrophenyl)ethanol, 97.0%, 10g

Guanine>98.0%(T)(HPLC)25g

2,3,7,8-Tetrafluorothianthrene 5-oxide, 97%, 1g

DMT-2'-Fluoro-dA(Bz) Phosphoramidite>90.0%(qNMR)250mg

2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

4-Amino-6-fluoro-5-methylpyrimidine, 95.0%, 250mg